Testing a new tool to detect lupus anticoagulant
Part of Heart & circulation clinical trials.
This trial checks if a new method (Cryocheck HexLA Integrated TCA) can accurately find lupus anticoagulant in blood samples. Your leftover blood from regular tests may be used, and it requires no extra visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your blood sample was sent to the Strasbourg University Hospital's hematology lab for routine lupus anticoagulant testing
- There is enough blood left over from your regular test
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a faster spinning method to measure how well your blood thinner (anti-Xa) is working when your blood sample is fatty. It may help ensure accurate results for patients on certain anticoagulants.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks for certain immune markers (HLA antibodies) in stored blood samples from people with lupus. It may help doctors understand how the immune system behaves in lupus.
This trial tests a new computer tool that helps doctors decide whether you likely have a blood clot in your leg or lung. If you have symptoms and are not already on blood thinners, you may be able to join.
This study tests whether lupus patients can use a home urine test to monitor their kidney health, which could help catch kidney problems early. It is for patients who have lupus and may have had kidney involvement before, or are at risk of developing it.
This study is building a national biobank (a storage of blood and health information) to learn more about lupus in people who were recently diagnosed (within the last 2 years). It's for patients whose lupus is not causing serious damage to major organs, so that researchers can study how the disease behaves early on.
Hear when a new Lupus Anticoagulant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.